Nuvation Bio Inc. (NUVB): Cost of Revenue

Annual figures by period end, from SEC filings.

$7.08M
Year ended 2024-12-31
2023-12-31: $02024-12-31: $7.08M$7.08M
2023-12-31 Cost of Revenue (USD) 2024-12-31
Period endedCost of RevenueChange YoYSource filing
2024-12-31$7.08Mn/a2025-03-06, From 2024-01-01
2023-12-31$0n/a2025-03-06, From 2023-01-01